Denali Advisors LLC bought a new stake in AlloVir in the third quarter valued at $51,000.

Source: https://www.americanbankingnews.com/2023/04/24/allovir-inc-nasdaqalvr-ceo-diana-brainard-sells-8408-shares.html

That's because on Wednesday in an SEC Filing, it was noted that had purchased about 2.9 million AlloVir shares at $3.75 apiece.

Source: https://seekingalpha.com/article/4614740-allovir-several-late-stage-programs-makes-this-worth-a-look?source=feed_all_articles

The company is an affiliate of ElevateBio, whose raison d’etre is to leverage its cell and gene therapy manufacturing capabilities into ownership interests of companies such as AlloVir – a sort of hedge fund hotel for biotechs.

Source: https://seekingalpha.com/article/4631341-allovir-an-intriguing-3-dollars-per-share-biotech-concern?source=feed_all_articles